Novartis Oncology Director of Business Development Salaries in Baltimore, MD
The average Novartis Oncology Director of Business Development in Baltimore, MD earns an estimated $181,596 annually, which includes an estimated base salary of $129,971 with a $51,625 bonus. Novartis Oncology's Director of Business Development compensation is $15,330 more than the US average for a Director of Business Development. Director of Business Development salaries at Novartis Oncology in Baltimore, MD can range from $83,500 - $248,000.
In Baltimore, MD, The Business Development Department at Novartis Oncology earns $11,203 more on average than the Finance Department.
Last updated 3 years ago.
- $129,971
- avg. base
- $51,625
- avg. bonus
Director of Business Development Salaries at Novartis Oncology
In Baltimore, MD, Directors of Business Development earn $723 more than Directors of Business Development.
Compensation at Novartis Oncology by Department
In Baltimore, MD, The Business Development Department averages $11,203 more than the Finance Department, and $5,123 less than the IT Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Novartis Oncology reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Novartis Oncology reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Novartis Oncology Rate Their Compensation
The majority of Directors of Business Development at Novartis Oncology believe they're not compensated fairly. 100% of Directors of Business Development at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
